Effect Of Fluticasone Propionate/Salmeterol (250/50) On Arterial Stiffness In Patients With COPD

被引：0
|
作者：
Dransfield, M. T.
Cockcroft, J.
Townsend, R.
Coxson, H. O.
Sharma, S.
Rubin, D.
Emmett, A.
Cicale, M.
Crater, G.
Martinez, F. J.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2631
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
    Dransfield, Mark T.
    Feldman, Gregory
    Korenblat, Phillip
    LaForce, Craig F.
    Locantore, Nicholas
    Pistolesi, Massimo
    Watkins, Michael L.
    Crim, Courtney
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2014, 108 (08) : 1171 - 1179
  • [32] Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma
    Delea, Thomas E.
    Hagiwara, May
    Stempel, David A.
    Stanford, Richard H.
    ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (03) : 211 - 218
  • [33] Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen, Adrian
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (01) : 105 - 105
  • [34] Advair diskus 250/50 - Fluticasone 250 pg and salmeterol 50 pg inhalation powder - Glaxosmithkline - Novel therapy for COPD
    不详
    FORMULARY, 2004, 39 (01) : 6 - 7
  • [35] Cost-effectiveness of salmeterol/fluticasone propionate in the treatment of COPD
    Earnshaw, Stephanie R.
    Wilson, Michele R.
    Blanchette, Christopher M.
    Mapel, Doug W.
    CHEST, 2007, 132 (04) : 528S - 528S
  • [36] Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review
    Calzetta, Luigino
    Ritondo, Beatrice Ludovica
    Matera, Maria Gabriella
    Cazzola, Mario
    Rogliani, Paola
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (06) : 621 - 635
  • [37] Effectiveness of Fluticasone propionate with Salmeterol on COPD symptoms treatment.
    Orefice, U
    Da Broi, U
    Talmassons, G
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A525 - A525
  • [38] Genetic effects on efficacy to fluticasone propionate/salmeterol treatment in COPD
    Condreay, Lynn D.
    Qu, Xiaoyan A.
    Anderson, Julie
    Compton, Chris
    Ghosh, Soumitra
    RESPIRATORY MEDICINE, 2019, 155 : 51 - 53
  • [39] Effect of Fluticasone/Salmeterol on Sleep Quality in Patients with COPD
    Banta, E. M.
    Mende, C.
    Rhoads, C.
    Craig, T. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB43 - AB43
  • [40] Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma.
    Shapiro, G
    Lumry, W
    Wolfe, J
    Given, J
    White, MV
    Woodring, A
    Baitinger, L
    House, K
    Prillaman, B
    Shah, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) : 527 - 534
12345